-The Times of India NEW DELHI: The government has invoked special powers under the law to prohibit stent makers from withdrawing their products from the market for the next six months. Amid reports that several manufacturers, including Abbott and Medtronic, are seeking to withdraw premium, high-priced stents from the Indian market on account of the price cap imposed by National Pharmaceutical Pricing Authority (NPPA), the government has directed companies to maintain production,...
More »SEARCH RESULT
Generic prescription hurdles
-The Telegraph New Delhi: Regulatory efforts to get doctors in India to prescribe medicines only through their generic names, initiated about 15 years ago, will need to overcome legal challenges and resistance from sections of doctors and the pharmaceutical industry, experts said. Senior pharmacologists and industry analysts have also said it will be misleading to presume that prescriptions with generic names will automatically translate into lower medicine bills for patients as studies...
More »Drumsticks beat back poverty in arid zones -Hiren Kumar Bose
-The Hindu Business Line Superfood moringa is proving to be a boon for subsistence farmers Names like PKM 2, Bhagya KDM 1, Rohit 1, Siddhi Vinayaka.... may not ring a bell among urban readers, but those engaged in subsistence farming will recognise these as the high-yielding varieties of Moringa olifera (drumstick tree). This tree (called murungae in Tamil) has been around for ages, but ever since the world at large claimed moringa as...
More »Not consulted on scrapping drug pricing agency: Chairman -Vidya Krishnan
-The Hindu New Delhi: Days after it was revealed that the Centre is likely to dismantle the National Pharmaceutical Pricing Agency (NPPA), its chairman said the decision was ‘rushed’ and the agency was not consulted. “There were two meetings and the NPPA was not a party to them. Both meetings were held at short notice. This has been a rushed decision. For any policy change, there needs to be consultation. I understand...
More »Government served legal notice over decision to cut NPPA's powers -Prabha Raghavan
-The Economic Times NEW DELHI: Civil society group All India Drug Action Network (AIDAN) has sent legal notices to Niti Aayog CEO and secretaries to the health ministry, department of Pharmaceuticals and department of industrial policy and promotion over their talks to cut powers of the National Pharmaceutical Pricing Authority. The group has termed the move “anti-national” and “anti-people”, adding that it affects an ongoing case at the Supreme Court over various...
More »